These Analysts Revise Their Forecasts On Revvity Following Q3 Results
These Analysts Revise Their Forecasts On Revvity Following Q3 Results
"We performed well during the third quarter with a return to positive revenue growth, strong margins, and another period of excellent cash flow," said Prahlad Singh, president and chief executive officer of Revvity. "The impact we are having on our customers every day to help to advance science and healthcare is profound, and we are optimistic that we can increasingly make a meaningful difference around the world as we continue to innovate and partner with purpose."Revvity, Inc. (NYSE:RVTY) reported better-than-expected third-quarter earnings on Monday.
Revvity 公司（紐交所：RVTY）週一報道第三季度收益好於預期。
The company posted quarterly earnings of $1.28 per share which beat the analyst consensus estimate of $1.13 per share. The company reported quarterly sales of $684.05 million which beat the analyst consensus estimate of $679.65 million.
該公司每股季度收益爲1.28美元，超過了分析師共識預期的1.13美元。該公司季度銷售額爲68405萬美元，超過了分析師共識預期的67965萬美元。
Revvity also authorized a new $1 billion share repurchase program.
Revvity 還授權了一項新的10億美元股份回購計劃。
"We performed well during the third quarter with a return to positive revenue growth, strong margins, and another period of excellent cash flow," said Prahlad Singh, president and chief executive officer of Revvity. "The impact we are having on our customers every day to help to advance science and healthcare is profound, and we are optimistic that we can increasingly make a meaningful difference around the world as we continue to innovate and partner with purpose."
「第三季度表現良好，實現了營收增長，較強的利潤率和又一個優秀現金流期。」，Revvity 公司總裁兼首席執行官普拉拉德·辛格表示，「我們每天對客戶產生的影響有助於推動科學和醫療保健，在創新和目的合作的過程中，我們對能夠在全球產生更有意義的影響感到樂觀。」
Revvity shares gained 0.4% to trade at $125.37 on Tuesday.
Revvity股票週二上漲0.4％，報125.37美元。
These analysts made changes to their price targets on Revvity following earnings announcement.
這些分析師在 Revvity 公佈收入公告後對其價格目標進行了調整。
- Raymond James analyst Andrew Cooper maintained Revvity with an Outperform and raised the price target from $144 to $146.
- Baird analyst Catherine Ramsey maintained the stock with an Outperform and increased the price target from $136 to $138.
- TD Cowen analyst Dan Brennan maintained Revvity with a Buy and raised the price target from $141 to $144.
- Bernstein analyst Eve Burstein maintained Revvity with an Outperform and cut the price target from $150 to $145.
- 雷蒙德詹姆斯分析師安德魯·庫珀維持 Revvity 爲「表現優異」，將目標股價從144美元上調至146美元。
- 貝爾分析師凱瑟琳·拉姆齊維持該股爲「表現優異」，將目標股價從136美元上調至138美元。
- TD Cowen分析師Dan Brennan保持對Revvity的買入評級，並將目標股價從141美元上調至144美元。
- Bernstein分析師Eve Burstein維持對Revvity的表現評級，並將目標股價從150美元下調至145美元。
Considering buying RVTY stock? Here's what analysts think:
考慮買入RVTY股票嗎？以下是分析師的看法：
- This eBay Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
- 這位ebay分析師看好；以下是週二的前5項升級
譯文內容由第三人軟體翻譯。
